scholarly journals Alterations in the Intestinal Morphology, Gut Microbiota, and Trace Mineral Status Following Intraamniotic Administration (Gallus gallus) of Genistein

2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 307-307
Author(s):  
Jacquelyn Cheng ◽  
Philip Sisser ◽  
Nikolai Kolba ◽  
Elad Tako
Keyword(s):  
Body Weight ◽  
Gut Microbiota ◽  
Physiological Role ◽  
Gallus Gallus ◽  
Intestinal Morphology ◽  
Intestinal Microbiome ◽  
Physiological Status ◽  
Rrna Gene ◽  
Divalent Metal Transporter 1 ◽  
Divalent Metal Transporter

Abstract Objectives Assess the effects of intraamniotic genistein administration on brush border membrane (BBM) functionality, intestinal morphology, cecal microbiome and Fe status in-vivo (Gallus gallus). Methods Broiler chickens (Gallus gallus, n = 39) were injected in ovo (day 17 of embryonic incubation) with varying concentrations of 1 mL pure genistein in 18 Ω H2O. Two treatment groups (1.25, 2.5%), two controls (water and non-injected), and a positive control (5% inulin) were administered. Upon hatch, blood was taken for hemoglobin determination and chicks were then euthanized. Nutritional status was assessed using pectoral muscle glycogen storage and body weight analysis. Duodenal and cecal tissues were excised for BBM morphometric analysis, mRNA gene expression of relevant BBM Fe transporter proteins, and 16S rRNA gene sequencing was done to evaluate gut microbiota modulation in the intestinal cecum. Results Preliminary results reveal significant increase in body weight, decrease of cecum weight, and increase in villus surface area with the higher dose of genistein administration (P < 0.05) compared to controls. Blood hemoglobin was found to be increased in the genistein-treated groups when compared to the controls (P < 0.05). Additionally, genistein administration downregulated the expression of duodenal cytochrome B (DcytB) and divalent metal transporter 1 (DMT1) and upregulated the expression of ferroportin with a dose responsive effect, indicating improved Fe physiological status. Further, administration of genistein altered the composition and function of cecal microbiota. Conclusions Genistein is a compound present in multiple staple food crops, including soybeans and chickpeas, and may be extracted and potentially used to enhance dietary Fe bioavailability and improve Fe deficiency in vulnerable populations. Recent evidence suggests a physiological role for genistein administration in improving the functionality and development of the BBM, improving Fe status, affecting the intestinal microbiome, as well as improving physiological status. Funding Sources N/A.

scholarly journals Low Phytate Peas (Pisum sativum L.) Improve Iron Status, Gut Microbiome, and Brush Border Membrane Functionality In Vivo (Gallus gallus)

Nutrients ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 2563 ◽  
Author(s):  
Tom Warkentin ◽  
Nikolai Kolba ◽  
Elad Tako
Keyword(s):  
Iron Deficiency ◽  
Gut Microbiota ◽  
Brush Border ◽  
Brush Border Membrane ◽  
Iron Status ◽  
Gallus Gallus ◽  
Intestinal Microbiome ◽  
Physiological Status ◽  
Dietary Iron

The inclusion of pulses in traditional wheat-based food products is increasing as the food industry and consumers are recognizing the nutritional benefits due to the high protein, antioxidant activity, and good source of dietary fiber of pulses. Iron deficiency is a significant global health challenge, affecting approximately 30% of the world’s population. Dietary iron deficiency is the foremost cause of anemia, a condition that harms cognitive development and increases maternal and infant mortality. This study intended to demonstrate the potential efficacy of low-phytate biofortified pea varieties on dietary iron (Fe) bioavailability, as well as on intestinal microbiome, energetic status, and brush border membrane (BBM) functionality in vivo (Gallus gallus). We hypothesized that the low-phytate biofortified peas would significantly improve Fe bioavailability, BBM functionality, and the prevalence of beneficial bacterial populations. A six-week efficacy feeding (n = 12) was conducted to compare four low-phytate biofortified pea diets with control pea diet (CDC Bronco), as well as a no-pea diet. During the feeding trial, hemoglobin (Hb), body-Hb Fe, feed intake, and body weight were monitored. Upon the completion of the study, hepatic Fe and ferritin, pectoral glycogen, duodenal gene expression, and cecum bacterial population analyses were conducted. The results indicated that certain low-phytate pea varieties provided greater Fe bioavailability and moderately improved Fe status, while they also had significant effects on gut microbiota and duodenal brush border membrane functionality. Our findings provide further evidence that the low-phytate pea varieties appear to improve Fe physiological status and gut microbiota in vivo, and they highlight the likelihood that this strategy can further improve the efficacy and safety of the crop biofortification and mineral bioavailability approach.

scholarly journals High Myoglobin Diet Induced Colon Dysbiosis and Inflammation by Regulating Heme or Iron Metabolism

2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 590-590
Author(s):  
Shuai Jiang ◽  
Miao Zhang ◽  
Qian Li ◽  
Chunbao Li
Keyword(s):  
Oxidative Stress ◽  
Body Weight ◽  
Gut Microbiota ◽  
Negative Impact ◽  
16S Rrna Gene Sequencing ◽  
Intestinal Morphology ◽  
Rrna Gene ◽  
Low Grade ◽  
Colon Tissue ◽  
Proinflammatory Factors

Abstract Objectives Changes in the gut microbiota caused by excessive meat consumption are often accompanied by various metabolic and inflammatory disorders, which are also largely related to the time and amount of dietary proteins. Myoglobin, a pigment in meat, which is difficult to digest. This study aimed to evaluate how the amount of myoglobin diets affected oxidative stress and colon homeostasis in mice. Methods C57BL/6J mice were fed casein, low-myoglobin (LMb), medium-myoglobin (MMb) or high-myoglobin (HMb) diets for 3 or 8 weeks (n = 10 each group). Proinflammatory factors and intestinal morphology in colon tissue, heme and iron metabolites in duodenum tissue were detected, fecal metabonomic was analyzed by LC-MS and gut microbiota was analyzed by 16S rRNA gene sequencing. Results Increased intake of a myoglobin diet decreased body weight, causing low-grade inflammation and colonic hyperplasia. The mice fed with HMb diets had the lowest feed intake and body weight, upregulated proinflammatory factors including IL-6, IL-12, IL-1β and TNF-α, and iron metabolites including SLC46A1, Ferridin-H, HO-2, TFR2, but downregulated ZO-1 and occuludin. As the myoglobin content increased, the relative abundance of Akkermansia and Bifidobacterium in colon increased at 3 or 8 weeks, especially in MMb and HMb diets. In addition, myoglobin diets at 3 and 8 weeks upregulated cellular processes and signaling, lipid metabolism and genetic information processing, and downregulated enzyme families compared to the casein diet. These changes were related to tryptophan metabolism and steroid biosynthesis pathway. Conclusions The negative impact of a high myoglobin diet may cause intestinal oxidative stress, inflammation and colonic hyperplasia, induce dysbiosis of gut microbiota and metabolism in mice through releasing heme and iron. Funding Sources This work was supported by the grants from NSFC (32072211).

scholarly journals Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Lito E. Papanicolas ◽  
Sarah K. Sims ◽  
Steven L. Taylor ◽  
Sophie J. Miller ◽  
Christos S. Karapetis ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Relative Abundance ◽  
Haematological Malignancy ◽  
Amplicon Sequencing ◽  
Intestinal Microbiome ◽  
Rrna Gene ◽  
Conventional Chemotherapy ◽  
Myelosuppressive Chemotherapy ◽  
Gram Positive Bacteria ◽  
Faecal Samples

Abstract Background The gut microbiota influences many aspects of host physiology, including immune regulation, and is predictive of outcomes in cancer patients. However, whether conventional myelosuppressive chemotherapy affects the gut microbiota in humans with non-haematological malignancy, independent of antibiotic exposure, is unknown. Methods Faecal samples from 19 participants with non-haematological malignancy, who were receiving conventional chemotherapy regimens but not antibiotics, were examined prior to chemotherapy, 7–12 days after chemotherapy, and at the end of the first cycle of treatment. Gut microbiota diversity and composition was determined by 16S rRNA gene amplicon sequencing. Results Compared to pre-chemotherapy samples, samples collected 7–12 days following chemotherapy exhibited increased richness (mean 120 observed species ± SD 38 vs 134 ± 40; p = 0.007) and diversity (Shannon diversity: mean 6.4 ± 0.43 vs 6.6 ± 0.41; p = 0.02). Composition was significantly altered, with a significant decrease in the relative abundance of gram-positive bacteria in the phylum Firmicutes (pre-chemotherapy median relative abundance [IQR] 0.78 [0.11] vs 0.75 [0.11]; p = 0.003), and an increase in the relative abundance of gram-negative bacteria (Bacteroidetes: median [IQR] 0.16 [0.13] vs 0.21 [0.13]; p = 0.01 and Proteobacteria: 0.015 [0.018] vs 0.03 [0.03]; p = 0.02). Differences in microbiota characteristics from baseline were no longer significant at the end of the chemotherapy cycle. Conclusions Conventional chemotherapy results in significant changes in gut microbiota characteristics during the period of predicted myelosuppression post-chemotherapy. Further study is indicated to link microbiome changes during chemotherapy to clinical outcomes.

scholarly journals Sexually Dimorphic Regulation of Gut Microbiota and Body Weight by a Naturally Occurring Flavonoid

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 472-472
Author(s):  
Priyanka Sharma ◽  
Guojun Wu ◽  
Hong Ye ◽  
Yan Y Lam ◽  
Deeptha Kumaraswamy ◽  
...  
Keyword(s):  
Body Weight ◽  
Gut Microbiota ◽  
Intestinal Microbiome ◽  
Sexually Dimorphic ◽  
Female Mice ◽  
Diet Induced Obesity ◽  
Naturally Occurring ◽  
Principal Coordinates ◽  
Brown Adipose ◽  
Microbiota Structure

Abstract Objectives 7,8-Dihydroxyflavone (DHF) is a naturally occurring flavonoid that is being actively investigated as a therapeutic modality in the treatment of neurological disorders. A recent study also indicated that oral DHF supplementation protected female but not male mice from diet-induced obesity. However, the mechanisms underlying this sexually-dimorphic effects of DHF were not known. The aim of the work is to investigate the mechanisms underlying sex-specific effects of flavonoid. Methods Age-matched male and female mice were given ad libitum access to high fat-diet and drinking water containing vehicle or DHF for 12 weeks. Body weights, body composition, food, and water intake, were assessed. Immunohistological analysis, immunohistochemistry staining, plasma triglycerides, plasma bile acids, and hepatic lipids were investigated. Fresh fecal samples were collected, genomic DNA was extracted and hypervariable region V4 of the 16S rRNA gene was amplified. Gut microbiota structure was evaluated using alpha diversity indices and beta diversity distance metrices. Principal coordinates analysis (PCoA) was performed using the R “ape” package to visualize differences in gut microbiota structure between treatment groups along principal coordinates that accounted for most of the variations. Results Oral administration of DHF, remodels the intestinal microbiome of female, but not male, prior to divergence in body weight. This is concomitant with increase in brown adipose tissue thermogenesis, mediated by increased expression of UCP1 and Pgc -1α protecting the female mice from diet-induced obesity. Conclusions This study demonstrates sexually-dimorphic effects of a clinically relevant natural compound. Importantly, it points to a role for sex-dependent remodeling of the intestinal microbiome as a mechanism for weight control in females. Thus, our discoveries pave the way for personalized nutrition strategies that account for sex differences in metabolism. Funding Sources NIH.

scholarly journals Effects of 12 weeks of resistance training on gut microbiota composition of rats

2021 ◽  
Author(s):  
Alinne P. Castro ◽  
Keemilyn K. S. Silva ◽  
Claudia S. A. Medeiros ◽  
Fernanda Alves ◽  
Ronaldo C. Araujo ◽  
...  
Keyword(s):  
Body Weight ◽  
Resistance Training ◽  
Gut Microbiota ◽  
16S Rrna Gene Sequencing ◽  
Tolerance Test ◽  
Rrna Gene ◽  
Microbiota Composition ◽  
Lower Body Weight ◽  
Rrna Gene Sequencing ◽  
Gut Microbiota Composition

In addition to its health benefits, exercise training has been pointed out as modulator of the gut microbiota. However, the effects of resistance training (RT) on gut microbiota composition remain unknown. Wistar rats underwent 12 weeks of RT. Body weight, glucose tolerance test, visceral body fat, triglyceride concentration, and food consumption were evaluated. The gut microbiota was analyzed by 16S rRNA gene sequencing. Rats that underwent RT showed lower body weight (p=0.0005), lower fat content (p=0.02), and better glucose kinetics (p=0.047) when compared to the control. Improvements in the diversity and composition of the gut microbiota were identified in the RT group. The relative abundance of Pseudomonas, Serratia, and Comamonas decreased significantly after 12 weeks of RT (p<0.001). These results suggest that RT has the potential to enhance the diversity of the gut microbiota and improve its biological functions.

scholarly journals The Effect of Exogenous Bile Acids on Antioxidant Status and Gut Microbiota in Heat-Stressed Broiler Chickens

2021 ◽  
Vol 8 ◽  
Author(s):  
Chang Yin ◽  
Bing Xia ◽  
Shanlong Tang ◽  
Aizhi Cao ◽  
Lei Liu ◽  
...  
Keyword(s):  
Heat Stress ◽  
Gut Microbiota ◽  
Bile Acids ◽  
Broiler Chickens ◽  
Antioxidant Status ◽  
Intestinal Morphology ◽  
Lipid Absorption ◽  
Rrna Gene ◽  
Sequencing Analysis ◽  
Crypt Depth

Bile acids are critical for lipid absorption, however, their new roles in maintaining or regulating systemic metabolism are irreplaceable. The negative impacts of heat stress (HS) on growth performance, lipid metabolism, and antioxidant status have been reported, but it remains unknown whether the bile acids (BA) composition of broiler chickens can be affected by HS. Therefore, this study aimed to investigate the modulating effects of the environment (HS) and whether dietary BA supplementation can benefit heat-stressed broiler chickens. A total of 216 Arbor Acres broilers were selected with a bodyweight approach average and treated with thermal neutral (TN), HS (32°C), or HS-BA (200 mg/kg BA supplementation) from 21 to 42 days. The results showed that an increase in average daily gain (P < 0.05) while GSH-Px activities (P < 0.05) in both serum and liver were restored to the normal range were observed in the HS-BA group. HS caused a drop in the primary BA (P = 0.084, 38.46%) and Tauro-conjugated BA (33.49%) in the ileum, meanwhile, the secondary BA in the liver and cecum were lower by 36.88 and 39.45% respectively. Notably, results were consistent that SBA levels were significantly increased in the serum (3-fold, P = 0.0003) and the ileum (24.89-fold, P < 0.0001). Among them, TUDCA levels (P < 0.01) were included. Besides, BA supplementation indeed increased significantly TUDCA (P = 0.0154) and THDCA (P = 0.0003) levels in the liver, while ileal TDCA (P = 0.0307), TLCA (P = 0.0453), HDCA (P = 0.0018), and THDCA (P = 0.0002) levels were also increased. Intestinal morphology of ileum was observed by hematoxylin and eosin (H&E) staining, birds fed with BA supplementation reduced (P = 0.0431) crypt depth, and the ratio of villous height to crypt depth trended higher (P = 0.0539) under the heat exposure. Quantitative RT-PCR showed that dietary supplementation with BA resulted in upregulation of FXR (P = 0.0369), ASBT (P = 0.0154), and Keap-1 (P = 0.0104) while downregulation of iNOS (P = 0.0399) expression in ileum. Moreover, 16S rRNA gene sequencing analysis and relevance networks revealed that HS-derived changes in gut microbiota and BA metabolites of broilers may affect their resistance to HS. Thus, BA supplementation can benefit broiler chickens during high ambient temperatures, serving as a new nutritional strategy against heat stress.

scholarly journals Effects of Xylo-Oligosaccharides on Growth and Gut Microbiota as Potential Replacements for Antibiotic in Weaning Piglets

2021 ◽  
Vol 12 ◽  
Author(s):  
Yuxia Chen ◽  
Yining Xie ◽  
Ruqing Zhong ◽  
Lei Liu ◽  
Changguang Lin ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Basal Diet ◽  
Intestinal Morphology ◽  
Short Chain ◽  
Control Group ◽  
Rrna Gene ◽  
Weaned Piglets ◽  
Villus Height ◽  
Crypt Depth ◽  
Weaning Piglets

Xylo-oligosaccharides (XOS) is a well-known kind of oligosaccharide and extensively applied as a prebiotic. The objective of this study was to investigate the effect of XOS supplementation substituting chlortetracycline (CTC) on growth, gut morphology, gut microbiota, and hindgut short chain fatty acid (SCFA) contents of weaning piglets. A total of 180 weaned piglets were randomly allocated to three treatments for 28 days, as follows: control group (basal diet, CON), basal diet with 500 mg/kg (XOS500) XOS, and positive control (basal diet with 100 mg/kg CTC). Compared with the CON group, the piglets in the XOS500 group improved body weight (BW) on days 28, average daily gain (ADG) and reduced feed: gain ratio during days 1–28 (P < 0.05). The XOS500 supplementation increased Villus height and Villus height: Crypt depth ratio in the ileum (P < 0.05). Villus Height: Crypt Depth of the ileum was also increased in the CTC treatment group (P < 0.05). Meanwhile, the XOS500 supplementation increased significantly the numbers of goblet cells in the crypt of the cecum. High-throughput 16S rRNA gene sequencing revealed distinct differences in microbial compositions between the ileum and cecum. XOS500 supplementation significantly increased the bacterial diversity. However, CTC treatment markedly reduced the microbial diversity (P < 0.05). Meanwhile, XOS500 supplementation in the diet significantly increased the abundance of Lactobacillus genus compared to the CON and CTC group in the ileum and cecum (P < 0.01), whereas the level of Clostridium_sensu_stricto_1, Escherichia-Shigella, and Terrisporobacter genus in the XOS500 group were markedly lower than the CON and CTC group (P < 0.05). In addition, dietary supplementation with XOS500 significantly increased the total short-chain fatty acids, propionate and butyrate concentrations and decreased the acetate concentration compared to the CON group in the cecum (P < 0.05). In summary, dietary supplemented with XOS500 could enhance specific beneficial microbiota abundance and decrease harmful microbiota abundance to maintain the structure of the intestinal morphology and improve growth performance of weaned piglets. Thus, XOS may potentially function as an alternative to in-feed antibiotics in weaned piglets in modern husbandry.

scholarly journals The Microbiota Diversity Following Antibiotic Treatment of Clostridium Difficile Infection

2020 ◽  
Author(s):  
Dana Binyamin ◽  
Orna Nitzan ◽  
Maya Azrad ◽  
Zohar Hamo ◽  
Omry Koren ◽  
...  
Keyword(s):  
Clostridium Difficile ◽  
Gut Microbiota ◽  
Antibiotic Treatment ◽  
Gut Microbiome ◽  
Diarrheal Disease ◽  
Medical Center ◽  
Disease Onset ◽  
Intestinal Microbiome ◽  
Rrna Gene ◽  
Stool Samples

Abstract Background: Clostridium difficile (C. difficile) is a major nosocomial pathogen that infects the human gut and can cause diarrheal disease. A dominant risk factor is antibiotic treatment that disrupts the normal gut microbiota. The aim of the study was to examine the correlation between antibiotic treatment received prior to C. difficile infection (CDI) onset and patient gut microbiota.Methods: Stool samples were collected from patients with CDI, presenting at the Baruch Padeh Medical Center Poriya, Israel. Demographic and clinical information, including previous antibiotic treatments, was collected from patient charts, and CDI severity score was calculated. Bacteria were isolated from stool samples, and gut microbiome was analyzed by sequencing the 16S rRNA gene using the Illumina MiSeq platform and QIIME2.Results: In total, 84 patients with C. difficile infection were enrolled in the study; all had received antibiotics prior to disease onset. Due to comorbidities, 46 patients (55%) had received more than one class of antibiotics. The most common class of antibiotics used was cephalosporins (n=44 cases). The intestinal microbiota of the patients was not uniform. Differences in intestinal microbiome were influenced by the different combinations of antibiotics that the patients had received (p = 0.022)Conclusions: The number of different antibiotics administered has a major impact on the CDI patients gut microbiome, mainly on bacterial richness.

scholarly journals Microbiota diversity following antibiotic treatment of Clostridium difficile infection

2020 ◽  
Author(s):  
Dana Binyamin ◽  
Orna Nitzan ◽  
Maya Azrad ◽  
Zohar Hamo ◽  
Omry Koren ◽  
...  
Keyword(s):  
Clostridium Difficile ◽  
Gut Microbiota ◽  
Antibiotic Treatment ◽  
Gut Microbiome ◽  
Diarrheal Disease ◽  
Medical Center ◽  
Disease Onset ◽  
Intestinal Microbiome ◽  
Rrna Gene ◽  
Stool Samples

Abstract Background: Clostridium difficile (C. difficile) is a major nosocomial pathogen that infects the human gut and can cause C. difficile infection (CDI), a diarrheal disease. A dominant risk factor is antibiotic treatment, which disrupts the normal gut microbiota. The aim of the study was to examine the correlation between antibiotic treatment received prior to CDI onset and patient gut microbiota during the infection.Methods: Stool samples were collected from patients with CDI, presenting at the Baruch Padeh Medical Center Poriya, Israel. Demographic and clinical information, including previous antibiotic treatments, was collected from patient charts, and CDI severity score was calculated. Bacteria were isolated from stool samples, and gut microbiome was analyzed by sequencing the 16S rRNA gene, using the Illumina MiSeq platform and QIIME2.Results: In total, 84 patients with CDI were enrolled in the study; all had received antibiotics prior to disease onset. Due to comorbidities, 46 patients (55%) received more than one class of antibiotics. The most common class of antibiotics used was cephalosporins (n=44 cases). The intestinal microbiota of the patients was not uniform. Differences in intestinal microbiome were influenced by the different numbers of antibiotics families that the patients received (p = 0.022)Conclusions: The number of different antibiotics amount has a major impact on the gut microbiome of CDI patients, particularly on its bacterial richness.

scholarly journals Fluoxetine-induced alteration of murine gut microbial community structure: evidence for a microbial endocrinology-based mechanism of action responsible for fluoxetine-induced side effects

PeerJ ◽  
2019 ◽  
Vol 7 ◽  
pp. e6199 ◽  
Author(s):  
Mark Lyte ◽  
Karrie M. Daniels ◽  
Stephan Schmitz-Esser
Keyword(s):  
Body Weight ◽  
Weight Gain ◽  
Side Effects ◽  
Gut Microbiota ◽  
Microbial Communities ◽  
Time Course ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Sequence Data ◽  
Rrna Gene ◽  
Dosing Regimen

Background Depression and major depressive disorder affect 25% of the population. First line treatment utilizing selective serotonin reuptake inhibitors (SSRIs) have met with limited success due to well-recognized negative side effects which include weight gain or loss. This inability to control unwanted side effects often result in patients stopping their antidepressant medications. The mechanisms underlying the failure of SSRIs are incompletely understood. Methods Male CF-1 mice (5 weeks of age, N = 10 per group) were per orally administered fluoxetine (20 mg per kg body weight) or diluent daily for 29 days. During this time fecal specimens were collected at three defined time points (0, 15 and 29 days). At the conclusion of the 29-day dosing regimen, animals were subjected to two behavioral assessments. For bacterial identification of the microbiota, 16S rRNA gene sequencing was performed on 60 fecal specimens (three specimens per mouse time course, N = 20 mice) using Illumina MiSeq. Analysis of community sequence data was done using mothur and LEfSe bioinformatic software packages. Results Daily per oral administration of fluoxetine for 29 days to male mice resulted in a significant, time dependent, alteration in microbial communities accompanying changes in body weight. The calculated species richness and diversity indicators of the murine fecal microbial communities were inconsistent and not significantly different between the groups. Among the phylotypes decreased in abundance due to fluoxetine administration were Lactobacillus johnsonii and Bacteroidales S24-7 which belong to phyla associated with regulation of body mass. The observed changes in body weight due to fluoxetine administration mimicked the dramatic shifts in weight gain/loss that has been observed in humans. Further, at the conclusion of the 29-day dosing regimen fluoxetine-dosed animals evidenced a mild anxiogenic-like behavior. Discussion We report that the most widely used antidepressant, fluoxetine, which is an SSRI-type drug, results in the selective depletion of gut microbiota, specifically the Lactobacilli which are involved in the regulation of body weight. Concomitantly, fluoxetine administration increases the abundance of phylotypes related to dysbiosis. Since Lactobacilli have been previously shown to possess a known biogenic amine transporter that regulates the uptake of fluoxetine, it is proposed that a microbial endocrinology-based mechanistic pathway is responsible for the ability of SSRIs to selectively negatively impact beneficial microbiota. The results of this study therefore suggest that the negative clinical side effects due to fluoxetine administration may be due to alterations in gut microbiota. Further, the data also suggests that supplementation of bacterial genera directly affected by fluoxetine administration may prove useful in ameliorating some of the well-known side effects of chronic fluoxetine administration such as weight alterations.

Sign in / Sign up

Export Citation Format

Share Document